Jesse Neri
Director of Finance/CFO bei ROCKWELL MEDICAL, INC.
Vermögen: 55 328 $ am 31.03.2024
Profil
Jesse Neri is a professional who currently holds the position of Senior Vice President-Finance at Rockwell Medical, Inc. She previously worked as Senior Vice President-Finance at Zyla Life Sciences LLC.
Ms. Neri completed her undergraduate degree at Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0,11% | 14.03.2024 | 33 330 ( 0,11% ) | 55 328 $ | 31.03.2024 |
Aktive Positionen von Jesse Neri
| Unternehmen | Position | Beginn |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Director of Finance/CFO | 18.10.2023 |
Ehemalige bekannte Positionen von Jesse Neri
| Unternehmen | Position | Ende |
|---|---|---|
| ZYLA LIFE SCIENCES | Corporate Officer/Principal | - |
Ausbildung von Jesse Neri
| Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
